Wreven, E; de Adana, MSR; Hardiville, S; Gmyr, V; Kerr-Conte, J; Chetboun, M; Pasquetti, G; Delalleau, N; Thévenet, J; Coddeville, A; Herrera, MJV; Hinden, L; Espínola, ICB; Duro, MG; Salido, LS; Linares, F; Bermúdez-Silva, FJ; Tam, J; Bonner, C; Egan, JM; Olveira, G; Colomo, N; Pattou, F; González-Mariscal, I – 2024 – 10.1007/s00125-024-06193-6
Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans – DIABETOLOGIA
por prodriguez | Ene 1, 2024 | Publicaciones - A-01, Publicaciones - C-01 | 0 Comentarios